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Lack or defective expression of the forkhead 
transcription  factor  (FoxP3)  causes  lethal   
X-linked CD4 T cell–dependent Th1- and 
Th2-driven autoimmune disease in both mice 
(Brunkow et al., 2001; Fontenot et al., 2003; 
Khattri et al., 2003) and men (Bennett et al., 
2001; Wildin et al., 2001) as a result of lack 
of FoxP3-dependent regulatory T cells (Treg 
cells).  This  is  mainly  dependent  on  CD4   
T cells, as depletion of CD4, but not CD8, 
T cells abrogates disease either genetically or 
with mAbs (Blair et al., 1994). The murine 
model is therefore particularly valuable for 
identifying pathways that might ameliorate 
clinical autoimmune disease in humans. We 
have previously shown that the TNF recep-
tors OX40 and CD30 play synergistic roles 
in the generation of CD4 memory/effector 
responses  (Kim  et  al.,  2003;  Gaspal  et  al., 
2005,  2008)  and  are  also  required  for  the 
maintenance of memory CD4 cells within 
the lamina propria of the gut (Withers et al., 
2009). We show in this paper that FoxP3 
Treg cells are dispensable in mice deficient in 
OX40  and  CD30  signals.  FoxP3-deficient 
mice lacking OX40 and CD30 develop and 
grow normally, fail to develop clinically rel-
evant autoimmune disease, and have a nor-
mal  lifespan.  We  also  show  that  blocking 
mAbs to OX40 and CD30 ligands abrogates 
development of FoxP3KO disease. This study 
highlights  the  critical  importance  of  both 
these signals in effector CD4 function and 
suggests that blocking both these signaling 
pathways  in  human  autoimmune  disease 
might be particularly effective at ameliorat-
ing disease.
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Our previous studies have implicated signaling through the tumor necrosis family recep-
tors OX40 and CD30 as critical for maintaining CD4 memory responses. We show that 
signals through both molecules are also required for CD4 effector-mediated autoimmune 
tissue damage. Under normal circumstances, male mice deficient in the forkhead tran-
scription factor FoxP3, which lack regulatory CD4 T cells, develop lethal autoimmune 
disease in the first few weeks of life. However, in the combined absence of OX40 and 
CD30, FoxP3-deficient mice develop normally and breed successfully. The extensive tissue 
infiltration and organ destruction characteristic of FoxP3 disease does not appear in these 
mice, and their mortality is not associated with autoimmunity. Although the absence of 
OX40 plays the dominant role, FoxP3-deficient mice sufficient in CD30 but deficient in 
OX40 signals still eventually develop lethal disease. This result was supported by the 
observation that blocking antibodies to OX40 and CD30 ligands also abrogated disease 
mediated by FoxP3-deficient T cells. These observations identify OX40 and CD30 signals 
as essential for the development of clinically relevant CD4-dependent autoimmunity and 
suggest that combination therapies that abrogate these signals might be used to treat 
established human autoimmune diseases.
© 2011 Gaspal et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e1580 CD30 and OX40 drive autoimmunity in FoxP3KO mice | Gaspal et al.
FoxP3 is not required for prevention of inflammatory 
responses to gut microbiota in the absence of OX40  
and CD30 signals
In addition to regulating autoimmune T cells, FoxP3 is re-
quired for Treg cell–mediated counteraction of inflammation 
against commensal gut microbiota (Izcue et al., 2009). How-
ever, FoxP3KOdKO failed to develop any signs of macroscopic 
or microscopic inflammatory bowel disease, and examination 
of the lamina propria showed it to be normal (unpublished 
data), with the exception of a depletion of CD4 T cells similar 
to that observed in dKO mice (Withers et al., 2009).
Prevention of disease is dependent on both OX40 and CD30
To assess the individual contributions of OX40 and CD30   
to autoimmunity in FoxP3KO mice, FoxP3KOdKO female 
mice were bred with male OX40KO or CD30KO mice. As 
FoxP3KOdKO female mice have two copies of the FoxP3KO 
allele, all the male offspring of this breeding strategy are FoxP3KO 
with either a single OX40 (OX40het) or CD30 (CD30het) 
gene. Disease onset was delayed in both situations (P = 0.002 
for both genes) compared with FoxP3KOdKOhet mice, clearly 
demonstrating the relevance of both genes (Fig. 1 A). FoxP3KO 
mice lacking CD30, but which had a single copy of the   
OX40 gene (OX40hetCD30KO), developed severe eczematous 
skin lesions between 7 and 9 wk and were sacrificed for   
humane reasons. Disease onset was delayed even further in   
FoxP3KO mice lacking OX40 but sufficient in a single copy of 
the CD30 gene (OX40KOCD30het; P < 0.001); some devel-
oped eczematous skin between 10 and 12 wk without obvi-
ous weight loss, indicating an attenuated phenotype compared 
with FoxP3KOdKOhet mice (all dead by 5 wk with 40% 
body weight loss). This shows that OX40 plays the dominant 
role but that the contribution of CD30 is significant and acts 
cooperatively with OX40 to permit the emergence of auto-
immune pathology in the context of FoxP3 deficiency.
Abrogation of organ infiltration and high-titer 
autoantibodies and retention of lymphoid tissue 
architecture in FoxP3KOdKO mice
To exclude subclinical disease in FoxP3KOdKO mice, animals 
were sacrificed contemporaneously with FoxP3KOdKOhet 
RESULTS AND DISCUSSION
Generation and phenotype of FoxP3KO mice deficient  
in OX40 and CD30
To investigate the impact of abrogation of OX40 and CD30 
signals on the development of autoimmunity in FoxP3KO 
mice, male C57BL/6 mice, deficient in both OX40 and 
CD30 (double [d] KO), were crossed with females with a 
heterozygous  null  allele  for  the  X-linked  gene  FoxP3 
(FoxP3het). As expected, 50% of male offspring hetero-
zygous for expression of OX40 and CD30 (dKOhet) were 
FoxP3 deficient and developed lethal autoimmune disease 
at 4 wk (Fig. 1 A), characterized by weight loss (Fig. 1 B) 
and  scurfy  phenotype  (Fig.  1  C).  Because  OX40  and 
CD30 are linked genetically, offspring have a high proba-
bility of inheriting deficiency in both genes as a haplo-
type. Consequently, after an F1 intercross between male 
dKO mice and FoxP3hetdKOhet females, 50% of the F2 male 
progeny  were  FoxP3  deficient.  Within  this  population 
50%  were  dKOhet  and  50%  dKO.  In  contrast  to   
FoxP3KOdKOhet mice, which developed autoimmune dis-
ease and lost body weight, FoxP3KOdKO mice developed 
no  signs  of  disease  and  were  indistinguishable  in  their 
body  weight,  health,  and  behavior  from  normal  male 
mice of the same age (not depicted) or FoxP3+dKO mice 
(Fig. 1 B). As an example of their good health, breeding 
pairs between male FoxP3KOdKO mice and FoxP3hetdKO 
females were established, with consequent generation of 
female  mice  that  were  FoxP3KOdKO.  Like  their  male 
counterparts,  these  female  mice  developed  and  bred   
normally. We have now maintained a viable colony of 
FoxP3KOdKO mice for 24 mo, in which breeding pairs 
have averaged three litters (with a mean of five pups per 
litter). This contrasts with CD28KO FoxP3KO mice, which 
develop delayed disease from 90 d, with 50% lethality by 
160 d (Singh et al., 2007). From 8 mo of age, approxi-
mately two thirds of the FoxP3KOdKO mice started to 
develop eczema affecting their ears only but were other-
wise healthy with no evidence of abnormal behavior or 
weight loss. The remaining mice have developed no overt 
evidence of any abnormality and have survived for 12 mo 
or more.
Figure 1.  Deficiency in OX40 and CD30 confers protec-
tion from FoxP3-dependent autoimmunity. (A) Kaplan-Meier 
survival curve for FoxP3KOdKOhet (n = 30 males), FoxP-
3KOOX40KOCD30het (n = 8 males), FoxP3KOOX40hetCD30KO (n = 5 
males), and FoxP3KOdKO mice (n > 20 males and n > 30 females). 
(B) Body weight of WT male littermate controls (FoxP3hetdKOhet) 
and male FoxP3KOdKOhet mice taken at the time of sacrifice, 
FoxP3KOdKO male aged 5 wk, and old FoxP3KOdKO male mice 
(aged 8 mo) or dKO male mice (aged 8 mo). The horizontal bars 
show the median. *, P < 0.002. (C) Ear photograph of a 5-wk-old 
FoxP3KOdKOhet male with eczema and scurfy skin (top) and a 
FoxP3KOdKO male littermate (bottom). Data are representative of 
at least five separate experiments.JEM Vol. 208, No. 8  1581
Brief Definitive Report
histological evidence of disease. Although liver infiltration 
was less substantial in OX40het and CD30hetFoxP3KO mice, 
infiltrates were clearly much greater than FoxP3KOdKO 
mice (Fig. 2 B).
The hallmark of pathogenic human autoimmune anti-
bodies is their high titer and affinity. These autoantibodies 
also occur in FoxP3KO mice, for example against stomach mouse 
tissue (Fig. 2 C). Stomach antibodies were also clearly evident 
in FoxP3KOOX40het and FoxP3KOCD30het mice but at mini-
mal low titers in FoxP3KOdKO mice (Fig. 2 C) even when 
old (not depicted), consistent with our previously reported 
observations that both CD30 and OX40 are required to gen-
erate high-affinity antibodies (Gaspal et al., 2005). Autoanti-
bodies and tissue infiltrates were not observed in FoxP3+dKOhet 
or FoxP3+dKO mice (unpublished data).
Compared  with  normal  mice,  FoxP3KOdKOhet,  Fox-
P3KOOX40het, and FoxP3KOCD30het mice exhibited marked 
lymphadenopathy, and this was significantly but not completely 
attenuated in FoxP3KOdKO mice (Fig. S1, E and F). Naive 
CD4 T cells reside exclusively within secondary lymphoid   
organs like spleen and lymph node (Reinhardt et al., 2001). In 
FoxP3-deficient  human  disease,  autoimmunity  is  associated 
with immunodeficiency within the naive CD4 and also CD8 
T cell compartments in lymph nodes and spleen (Costa-
Carvalho et al., 2008). Compared with normal mice, FoxP3KO 
mice had grossly abnormal architecture, with destruction of 
white pulp areas of both lymph node 
and spleen (Fig. 2, D and E), and this 
was  associated  with  gross  depletion   
of  CD4+CD62Lhi  naive  T  cells   
(Fig. 3 A and Fig. S2). In contrast, in   
FoxP3KOdKO mice the spleen and 
lymph node architecture was normal, 
with well  organized  B  and  T  cell   
areas (Fig. 2, D and E). Although 
there was still marked skewing of 
CD4  T  cells  to  effector/memory 
phenotype CD62Llo cells, a signifi-
cant proportion of CD4 T cells were 
CD62Lhi naive cells. To a lesser extent, 
naive CD8 T cells were also reduced in 
littermates that developed overt disease. A striking feature of 
FoxP3 deficiency is an eczematous skin infiltration by T cells 
resulting in the scurfy phenotype with infiltration of the sub-
cutaneous tissues of the skin most obvious in the ear macro-
scopically (Fig. 1 C) but also by microscopy (Fig. 2 A). In 
contrast, the ears of FoxP3KOdKO mice appeared grossly and 
microscopically normal and were indistinguishable from WT 
normal mice. This did not simply reflect a delay in disease onset, 
as FoxP3KOdKO or FoxP3+dKO mice sacrificed at 180 d also   
appeared macroscopically and microscopically normal (Fig. S1, 
A–D). At later time points from 8 mo of age, some Fox-
P3KOdKO mice developed eczema affecting their ears, but the 
infiltrates were small and contained few CD4+ T cells (unpub-
lished data). No mice developed fatal autoimmune pathology.
In addition to skin T cell infiltration, at the time of clini-
cal disease onset, FoxP3KO mice develop lymphocyte infiltra-
tions in many other tissues including the liver. These infiltrates 
form substantial tertiary lymphoid structures in the liver of 
FoxP3KOCD30hetOX40het mice with focal aggregates of B220+ 
B and CD3+ T cells (Fig. 2 B). In contrast, in FoxP3KOdKO 
mice, there was virtually no infiltration by lymphocytes and cer-
tainly no organized aggregates were detected. FoxP3KOdKO 
mice sacrificed at 6 mo of age also showed a lack of tissue   
infiltration (Fig. S1 B).
After 8 mo, some mice also showed small CD4 T cell 
infiltrates in the liver, although 30% of mice showed no 
Figure 2.  Confocal micrographs of 
cryostat tissue sections and autoanti-
bodies from 4–5-wk-old FoxP3KO mice 
intact and deficient in OX40 and CD30 
signals. (A) Ear pinna (CD3, green; DAPI, 
blue). (B) Liver (DAPI, gray; CD3, red; B220, 
green; CD4, blue). (C) RAGKO stomach sec-
tions incubated with sera to identify auto-
antibodies. (D) Lymph node (IgM, green; CD3, 
red; FoxP3, white). (E) Spleen (IgM, green; 
CD3, red; CD11c, blue). Data are representa-
tive of at least 5 mice deficient in OX40 or 
CD30 and at least 10 different FoxP3KOdKO 
and FoxP3KOdKOhet mice. Bars, 50 µm.1582 CD30 and OX40 drive autoimmunity in FoxP3KO mice | Gaspal et al.
stimulation in vivo (Kim et al., 2005), but fail to be sustained as   
effector/memory cells (Gaspal et al., 2005, 2008). As reported 
previously by others, FoxP3KO mice have an increased frac-
tion of CD4+CD62LloCD44hi effector/memory cells that ex-
press more IL4 and IFN- than FoxP3+ mice (Fig. 3 B and 
Fig. S2). Compared with FoxP3KOdKOhet mice, expression 
of IL4 and IFN- in activated FoxP3KOdKO CD4 T cells 
was substantially reduced and little different from both WT 
and dKO mice sufficient in FoxP3 (Fig. 3).
In contrast to CD4 T cells, CD8 T cells from FoxP3KOdKO 
mice were not only highly activated but expressed high levels 
of IFN- compared with FoxP3-sufficient controls. CD8 
T  cells  are  implicated  in  the  immunopathology  of  auto-
immune diseases. Therefore, the failure of FoxP3KOdKO CD8 
T cells to cause disease suggests that CD8 immune-mediated 
damage in autoimmune diseases depends on OX40 and CD30 
signals to CD4 T cells, or alternatively the potential CD8-
mediated damage is much less than for CD4 T cells, confirm-
ing previous findings (Blair et al., 1994).
To test directly whether the defect in FoxP3KOdKO CD4 
T cells was a result of decreased survival, we transferred neo-
natal  thymocytes,  which  have  been  previously  shown  to 
transfer disease (Godfrey et al., 1994), from FoxP3KOdKOhet 
or FoxP3KOdKO mice into RAGKO recipients. RAGKO mice 
that received FoxP3KOdKOhet thymocytes developed disease at 
3 wk (Fig. S3 A). Both CD4 (Fig. S3 B) and CD8 (Fig. S3 C) 
T cells were activated (CD44hiCD62Llo) and a high proportion 
of both CD4 and CD8 T cells expressed IFN- (Fig. S3, 
B  and  C).  RAGKO  mice  injected  with  FoxP3KOdKO  or 
FoxP3+dKOhet thymocytes did not get sick. These mice 
were culled after 10 wk and their T lymphocytes analyzed.   
Although all the CD4 T cells were CD44hiCD62Llo (Fig. S3 B), 
far fewer CD4 cells (P < 0.05) were recovered from mice 
that  received  FoxP3KOdKO  thymocytes  compared  with   
FoxP3KOdKOhet or FoxP3+dKOhet thymocytes, and very few 
of these cells expressed IFN- (Fig. S3 D; P < 0.05). CD8 T cell 
numbers were also reduced, but the reduction was much less 
than for CD4 T cells, although the expression of IFN- was 
significantly less (P < 0.05; Fig. S3 D).
Blocking antibodies to OX40L and CD30L abrogate disease 
mediated by FoxP3KO T cells
To exclude effects of OX40 and CD30 on T cell development 
and to test whether in vivo blockade of OX40 and CD30 
signals might be effective in treating autoimmune disease, 107 
FoxP3KOdKOhet thymocytes were transferred into RAGKO 
mice. After transfer, mice received either twice weekly injec-
tions of blocking mAbs to OX40 and CD30 ligands (Akiba 
et al., 2000) or control rat IgG (see Materials and methods). 
Mice that received control rat IgG developed signs of FoxP3KO 
disease at 3 wk after transfer, whereas mice treated with   
blocking mAbs looked healthy at this time and remained 
healthy for several weeks even after blocking mAbs were 
stopped (Fig. 4 A). FACS analysis of these mice sacrificed at 
the same time as sick mice showed that they had reduced num-
bers of CD4+ T cells, and much reduced expression of IFN-, 
FoxP3KO mice but were restored in FoxP3KOdKO mice cells 
(Fig. 3).
CD4 T cells are activated but fail to express IL4 and IFN- 
in FoxP3KOdKO mice
Our previous studies have shown that dKO CD4 T cells pro-
liferate just as well as their WT counterparts both in vitro   
and in vivo (Gaspal et al., 2005), can be induced to express 
both Th1 and Th2 cytokines under appropriate conditions of 
Figure 3.  Activation status and cytokine expression from  
4–5-wk-old FoxP3KO mice with intact and deficient OX40 and 
CD30 signals. For cytokine expression, splenocytes from FoxP3KOdKOhet, 
FoxP3KOdKO, dKO (FoxP3+, OX40KO CD30KO), and WT mice were activated 
on anti-CD3–coated (5 µg/ml) plates in the presence of 0.5 µg/ml anti-
CD28 antibody. 4 h later, CD62Llo CD3+ T cells were analyzed for intra-
cellular IL4 and IFN-. (A) Lymphocyte gated cells. (B) Expression of CD62L 
on CD3+CD4+CD8+ gated T cells. Expression of IL4 (C) or IFN- (D) in 
CD62LloCD3+CD4+CD8+ gated T cells. (E) Representative FACS data from the 
different group of mice. The horizontal bars show the median (*, P < 0.002). 
Data are representative of four separate experiments.JEM Vol. 208, No. 8  1583
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microbiota in the gut (Izcue et al., 2009). However, in the 
absence of OX40 and CD30, there is no evidence of gut   
inflammation in the absence of Treg cells.
Therapeutic trials of anti-OX40 ligand mAbs are already in 
human clinical trials for asthma (Clinical Trials NCT00983658). 
This study highlights the crucial importance of both OX40 
and CD30 cells in mediating tissue damage in human auto-
immune diseases mediated by pathogenic CD4 T cells and 
suggests that strategies that block both pathways would act 
synergistically to prevent this damage occurring. In support 
of this, we showed that injection of blocking antibodies to 
OX40 and CD30 ligands could also prevent disease onset in an 
adoptive transfer model of FoxP3KO disease, emphasizing the 
potential therapeutic role in human autoimmune disease.
MATERIALS AND METHODS
Mice. All experiments on animals were approved by Birmingham University 
local ethical panel review and UK Home office guidelines. Animals were bred 
in accordance with home office guidelines at the University of Birmingham, 
Biomedical Services Unit. Heterozygous FoxP3het females were provided by 
A. Rudensky (Howard Hughes Medical Institute and Immunology Program, 
Memorial Sloan-Kettering Cancer Center, New York, NY) and were crossed 
with CD30KOOX40KO (dKO) or mice deficient in OX40 (OX40KO) or 
CD30 (CD30KO).
Thymocyte transfer. Approximately 10 × 106 FoxP3KO thymocytes from 
newborn (day 2–5) male FoxP3KO mice were injected i.v. into RAGKO mice 
to transfer FoxP3KO disease.
Blocking  antibody  injection.  Blocking  mAbs  against  mouse  OX40L 
(clone RM134L) and CD30L (clone RM153) were prepared as described 
previously (Akiba et al., 2000). Control rat IgG was purchased from Sigma-
Aldrich. Mice were twice weekly injected with either 0.5 mg anti-OX40L 
and 0.5 mg anti-CD30L mAbs or 1 mg of control IgG.
Immunofluorescence microscopy. 5-µM frozen tissue cryostat sections 
were stained with fluorescent antibodies as described previously (Kim et al., 
2003). Liver sections were pretreated with avidin/biotin block-
ing reagents (Sigma-Aldrich). Primary anti–mouse antibodies used 
were: anti-B220 biotin (clone RA3-6B2; eBioscience), anti-CD3 
FITC and biotin (145-2C11; BD), anti-CD4 Alexa Fluor 647 
(GK1.5; eBioscience), anti-CD11c biotin (N418; eBioscience), 
anti-IgM rhodamine red (Jackson ImmunoResearch Laborato-
ries,  Inc.),  CD4–Alexa  Fluor  647  (clone  L3T4),  and  anti-
FoxP3 FITC (FJK-16s). Biotinylated Abs were detected with 
streptavidin–Alexa  Fluor  555  or  streptavidin–Alexa  Fluor  647 
(Invitrogen). FITC-conjugated Abs were detected using rabbit 
similar to that observed for FoxP3KO dKO thymocytes trans-
fers (Fig. 4, B and C). Analysis of liver tissue in mice injected 
with blocking mAbs also showed that T cell infiltrates were 
much reduced (unpublished data). We do not think these mAbs 
are simply depleting cells that express these molecules, as 
lymphoid tissue inducer cells that express high levels of OX40 
and CD30 ligands (Kim et al., 2003) are not depleted by 
these mAbs (unpublished data).
To exclude effects of OX40 and CD30 on T cell activa-
tion, treatment with blocking mAbs was delayed for 8 d to 
allow FoxP3KO T cells to be fully activated. At this time point 
after transfer, FACS analysis of splenocytes showed that all 
transferred CD4 T cells were CD44hi and most were CD62Llo 
(Fig. S4). Injection of blocking mAbs from this time point 
again prevented disease onset in remaining RAGKO mice that 
received FoxP3KO thymocytes (Fig. 4 D).
We have previously shown that OX40 and CD30 signals 
are essential for the generation of CD4 memory antibody re-
sponses in mice (Gaspal et al., 2005). In this paper, we show 
that these signals, particularly the former, are required for the 
immunopathology driven by Th1 and Th2 FoxP3-deficient 
autoimmune effector CD4 T cells. The absence of lethal dis-
ease with minimal tissue infiltration in FoxP3KO mice lacking 
OX40 and CD30 demonstrates that these signals are crucial 
for effector CD4 T cell–driven autoimmune tissue damage. 
Molecular phylogeny shows that the TNF ligands for OX40 
and CD30 evolved late (Glenney and Wiens, 2007), as ortho-
logs of these genes are present only in mammals and birds (www 
.ensembl.org), which like mammals can develop spontaneous 
autoimmune disease (Wick et al., 2006). In contrast, there is 
little or no evidence that lower vertebrates lacking these genes 
spontaneously develop clinically relevant autoimmunity. In ad-
dition to suppressing autoimmunity, FoxP3-dependent Treg 
cells prevent inflammatory responses to food and commensal   
Figure 4.  Blocking mAbs to OX40L and CD30L prevent 
FoxP3 autoimmune disease. RAGKO mice were transferred 
with 107 FoxP3KO thymocytes and treated with biweekly injec-
tions of either 1 mg of control rat IgG or 0.5 mg OX40L and 
0.5 mg CD30L mAbs. (A) Kaplan-Meier survival curve (four 
mice in each group). (B) IFN- cytokine production analysis of 
gated CD3+ T cells 3 wk after transfer. (C) Number of CD4+  
T cells and IFN-+ CD44+ CD4+ T cells in the spleen 3 wk after 
transfer. The horizontal bars show the median (*, P < 0.02).  
(D) Kaplan-Meier survival curve when the antibody treatment 
was delayed for 8 d. Arrows indicate when mAb therapy was 
started and when it was stopped. Data are representative of 
two separate experiments.1584 CD30 and OX40 drive autoimmunity in FoxP3KO mice | Gaspal et al.
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anti-FITC Abs (Invitrogen) and then goat anti–rabbit FITC Abs (Southern-
Biotech). IgG autoantibodies were detected by adding sera (diluted 1/40 in 1% 
BSA/PBS) to RAGKO stomach sections followed by goat anti–mouse IgG   
Alexa Fluor 594 (Invitrogen). Sections were counterstained with DAPI (In-
vitrogen) and mounted using DABCO (Sigma-Aldrich).
FACS and intracellular cytokine staining. Splenocytes prepared from 
the indicated mice were restimulated in vitro for 4 h at 37°C in the presence 
of GolgiStop (BD) on plates coated with 5 µg/ml anti-CD3 Ab and 0.5 µg/ml 
of soluble anti-CD28 Ab (BD). Cells were then surface stained with anti-
CD3 FITC, CD62L PE, CD8 PE Texas red, CD4 PE-Cy5.5, and CD44 
PECy7 (EBioscience) and then fixed and permeabilized with Cytofix/
Cytoperm Plus (BD) according to the manufacturer’s instructions. Intracel-
lular cytokine expression was revealed by staining permeabilized cells with 
APC-conjugated mAb to IFN- and IL4 (BD).
Statistics. Mann-Whitney nonparametric statistics were used throughout to 
analyze the significance of differences between groups of mice.
Online supplemental material. Fig. S1 shows confocal micrographs of 
cryostat tissue sections from Foxp3KOdKO mice aged 6 mo. Fig. S2 shows 
CD4 T cell number and activation status in FoxP3KOdKO mice. Fig. S3 
shows that RAGKO mice injected with FoxP3KOdKO thymocytes do not 
develop disease. Fig. S4 shows activation status of FoxP3KO CD4 T cells 8 d 
after transfer into RAGKO hosts compared with CD4+ T cells from WT 
C57BL/6 spleen. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20101484/DC1.
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